Anne Marijn Kramer

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Sara Ghorashian, Anne Marijn Kramer, Shimobi Onuoha et al. · Nature Medicine · 2019 · 613 citations

Cell Therapy, Prolonged Persistence, Autoimmune Disease +9

Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation

Anna Capsomidis, Gabriel Benthall, Heleen H. Van Acker et al. · Molecular Therapy · 2017 · 247 citations · Full text

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Astrid Olsnes Kittang, Shahram Kordasti, Kristoffer Sand et al. · OncoImmunology · 2015 · 134 citations · Full text

Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe

Anne Marijn Kramer, Karlijn J. van Stralen, Kitty J. Jager et al. · Kidney International · 2011 · 107 citations · Full text

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

Matthew J. Frank, John H. Baird, Anne Marijn Kramer et al. · The Lancet · 2024 · 45 citations · Full text